Coherent Market Insights published a business research report on Immune Repertoire Sequencing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2022–2028. Immune Repertoire Sequencing Market with 150+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. The information is gathered based on modern floats and requests identified with the administrations and items.
The global Immune Repertoire Sequencing Market analysis further provides pioneering landscape of market along with market augmentation history and key development involved in the industry. The report also features comprehensive research study for high growth potential industries professional survey with market analysis. Immune Repertoire Sequencing Market report helps the companies to understand the market trends and future market prospective,opportunities and articulate the critical business strategies.
Get FREE Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/1517
Expanding cancer research, rising government support for pharmacogenomics-based medication discovery, and rising number of development programs in different therapeutic regions including oncology, cardiology, infectious diseases, psychiatry, torment management, among others are central points expected to drive the growth of the immune repertoire sequencing market.
Besides, different organizations are zeroing in on growing new solutions to observe customized biomarkers in the immune system for better and prior finding of an illness, eventually driving the growth of the immune repertoire sequencing market. For instance, in 2013, the HudsonAlpha Institute for Biotechnology, U.S., initiated a project that expects to group 10,000 person’s T-cell repertoire on Illumina HiSeq and B-cell repertoire on Roche’s 454 GS FLX for analysis of a few diseases, including cancers, autoimmune diseases, inflammatory diseases, and infectious diseases.
Manufacturers in the immune repertoire sequencing market are zeroing in on strategic consolidations and acquisitions to acquire a significant market share. For instance, in March 2018, ArcherDX Inc. and Ambry Genetics entered into a strategic partnership to give immune repertoire sequencing administrations to biopharmaceutical customers. This partnership assisted both companies with expanding their product portfolio in the immune repertoire sequencing segment, globally. Likewise, in January 2018, Thermo Fisher Scientific and Illumina, Inc. declared an arrangement for a partnership. This agreement enables Illumina to offer Ion AmpliSeq technology to researchers who conduct scientific studies on Illumina’s next-generation sequencing (NGS) platforms.
Key Takeaways of the Immune Repertoire Sequencing Market:
- The size of the market is expected to expand at a CAGR of around 5.6% during the forecast time frame (2018-2026), attributable to expanding R&D and the requirement for repertoire and genomic sequencing-based research.
- Among product types, the assay kit segment is expected to hold a significant income share in 2026. Different companies are zeroing in on collaborations activities to foster immune repertoire sequencing-based kits for certain immunotherapy reactions, which is expected to drive the growth of the assay kits segment in the market. For instance, in April 2018, DiaCarta and MIODx entered into an agreement for the development of MIODx’s ClonoMap sequencing-based tests, to predict patient reaction to immunotherapy.
- Key players operating in the global immune repertoire sequencing market incorporate Takara Bio, Inc., Agilent Technologies, Inc., Qiagen N.V., Oxford Nanopore Technologies, Ltd., Adaptive Biotechnologies, Atreca, Inc., CD Genomics, Pacific Biosciences, Roche Holding AG, ArcherDX, Inc., Illumina Inc., and Thermo Fisher Scientific, Inc.
Buy This Report With USD 2000 Flat OFF – https://www.coherentmarketinsights.com/promo/buynow/1517
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Immune Repertoire Sequencing Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Immune Repertoire Sequencing Industry Impact
Chapter 2 Global Immune Repertoire Sequencing Competition by Types, Applications, and Top Regions and Countries
2.1 Global Immune Repertoire Sequencing (Volume and Value) by Type
2.3 Global Immune Repertoire Sequencing (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Immune Repertoire Sequencing Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Immune Repertoire Sequencing Market Analysis
Chapter 6 East Asia Immune Repertoire Sequencing Market Analysis
Chapter 7 Europe Immune Repertoire Sequencing Market Analysis
Chapter 8 South Asia Immune Repertoire Sequencing Market Analysis
Chapter 9 Southeast Asia Immune Repertoire Sequencing Market Analysis
Chapter 10 Middle East Immune Repertoire Sequencing Market Analysis
Chapter 11 Africa Immune Repertoire Sequencing Market Analysis
Chapter 12 Oceania Immune Repertoire Sequencing Market Analysis
Chapter 13 South America Immune Repertoire Sequencing Market Analysis
Chapter 14 Company Profiles and Key Figures in Immune Repertoire Sequencing Business
Chapter 15 Global Immune Repertoire Sequencing Market Forecast (2021-2027)
Chapter 16 Conclusions
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/1517
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027